Individualized antibiotic dosage regimens for patients with augmented renal clearance
Frontiers in Pharmacology · 26.07.2023 · 14
DOI: 10.3389/fphar.2023.1137975 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 26.07.2023. Verfasst von A-Xi Shi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Second Xiangya Hospital, Institute of Clinical Pharmacy, Central South University, Changsha, China. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 177 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
Augmented renal clearance (ARC) is a state of enhanced renal function commonly observed in 30%–65% of critically ill patients despite normal serum creatinine levels. Using unadjusted standard dosing regimens of renally eliminated drugs in ARC patients often leads to subtherapeutic concentrations, poor clinical outcomes, and the emergence of multidrug-resistant bacteria. We summarized pharmaceutical, pharmacokinetic, and pharmacodynamic research on the definition, underlying mechanisms, and risk factors of ARC to guide individualized dosing of antibiotics and various strategies for optimizing outcomes.
Methods
We searched for articles between 2010 and 2022 in the MEDLINE database about ARC patients and antibiotics and further provided individualized antibiotic dosage regimens for patients with ARC.
Results
25 antibiotic dosage regimens for patients with ARC and various strategies for optimization of outcomes, such as extended infusion time, continuous infusion, increased dosage, and combination regimens, were summarized according to previous research.
Conclusion
ARC patients, especially critically ill patients, need to make individualized adjustments to antibiotics, including dose, frequency, and method of administration. Further comprehensive research is required to determine ARC staging, expand the range of recommended antibiotics, and establish individualized dosing guidelines for ARC patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, The Second Xiangya Hospital, Institute of Clinical Pharmacy, Central South University, Changsha, China.
- Department of Pharmacy, The First Hospital of Lanzhou University, Lanzhou, China.
- Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, China.
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.
- Hunan Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, Changsha Medical University, Changsha, China.
Zitieren
APA
Shi, A. X., Qu, Q., Zhuang, H. H., Teng, X. Q., Xu, W. X., Liu, Y. P., Xiao, Y. W., & Qu, J. (2023). Individualized antibiotic dosage regimens for patients with augmented renal clearance. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1137975
Vancouver
Shi AX, Qu Q, Zhuang HH, Teng XQ, Xu WX, Liu YP, et al. Individualized antibiotic dosage regimens for patients with augmented renal clearance. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1137975
BibTeX
@article{Shi2023,
author = {Shi, A-Xi and Qu, Qiang and Zhuang, Hai-Hui and Teng, Xin-Qi and Xu, Wei-Xin and Liu, Yi-Ping and Xiao, Yi-Wen and Qu, Jian},
title = {Individualized antibiotic dosage regimens for patients with augmented renal clearance},
journal = {Frontiers in Pharmacology},
year = {2023},
volume = {14},
doi = {10.3389/fphar.2023.1137975}
}
EUVIMED